Literature DB >> 19201891

Cytolysins augment superantigen penetration of stratified mucosa.

Amanda J Brosnahan1, Mary J Mantz, Christopher A Squier, Marnie L Peterson, Patrick M Schlievert.   

Abstract

Staphylococcus aureus and Streptococcus pyogenes colonize mucosal surfaces of the human body to cause disease. A group of virulence factors known as superantigens are produced by both of these organisms that allows them to cause serious diseases from the vaginal (staphylococci) or oral mucosa (streptococci) of the body. Superantigens interact with T cells and APCs to cause massive cytokine release to mediate the symptoms collectively known as toxic shock syndrome. In this study we demonstrate that another group of virulence factors, cytolysins, aid in the penetration of superantigens across vaginal mucosa as a representative nonkeratinized stratified squamous epithelial surface. The staphylococcal cytolysin alpha-toxin and the streptococcal cytolysin streptolysin O enhanced penetration of toxic shock syndrome toxin-1 and streptococcal pyrogenic exotoxin A, respectively, across porcine vaginal mucosa in an ex vivo model of superantigen penetration. Upon histological examination, both cytolysins caused damage to the uppermost layers of the vaginal tissue. In vitro evidence using immortalized human vaginal epithelial cells demonstrated that although both superantigens were proinflammatory, only the staphylococcal cytolysin alpha-toxin induced a strong immune response from the cells. Streptolysin O damaged and killed the cells quickly, allowing only a small release of IL-1beta. Two separate models of superantigen penetration are proposed: staphylococcal alpha-toxin induces a strong proinflammatory response from epithelial cells to disrupt the mucosa enough to allow for enhanced penetration of toxic shock syndrome toxin-1, whereas streptolysin O directly damages the mucosa to allow for penetration of streptococcal pyrogenic exotoxin A and possibly viable streptococci.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201891      PMCID: PMC2805182          DOI: 10.4049/jimmunol.0803283

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  Resealing of large transmembrane pores produced by streptolysin O in nucleated cells is accompanied by NF-kappaB activation and downstream events.

Authors:  Iwan Walev; Michael Hombach; Wieslawa Bobkiewicz; Dominic Fenske; Sucharit Bhakdi; Matthias Husmann
Journal:  FASEB J       Date:  2001-12-14       Impact factor: 5.191

Review 2.  The systemic reaction during inflammation: the acute-phase proteins.

Authors:  Fabrizio Ceciliani; Alessia Giordano; Valentina Spagnolo
Journal:  Protein Pept Lett       Date:  2002-06       Impact factor: 1.890

3.  Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.

Authors:  Patrick M Schlievert; Timothy J Tripp; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

4.  Effect of antipyretics on group A streptococcal pyrogenic exotoxin fever production and ability to enhance lethal endotoxin shock.

Authors:  P M Schlievert; K M Bettin; D W Watson
Journal:  Proc Soc Exp Biol Med       Date:  1978-03

5.  Evidence for two molecular forms of streptococcal erythrogenic toxin. Conversion to a single form by 2-mercaptoethanol.

Authors:  C Nauciel; J Blass; R Mangalo; M Raynaud
Journal:  Eur J Biochem       Date:  1969-11

6.  An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections.

Authors:  Malak Kotb; Anna Norrby-Teglund; Allison McGeer; Hesham El-Sherbini; M Tevik Dorak; Ayesha Khurshid; Karen Green; Jeanie Peeples; Judy Wade; Glenys Thomson; Benjamin Schwartz; Donald E Low
Journal:  Nat Med       Date:  2002-11-18       Impact factor: 53.440

Review 7.  Cholesterol and the activity of bacterial toxins.

Authors:  Michael Palmer
Journal:  FEMS Microbiol Lett       Date:  2004-09-15       Impact factor: 2.742

Review 8.  The CC chemokine CCL20 and its receptor CCR6.

Authors:  Evemie Schutyser; Sofie Struyf; Jo Van Damme
Journal:  Cytokine Growth Factor Rev       Date:  2003-10       Impact factor: 7.638

9.  Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage.

Authors:  Catherine C Davis; Mary J Kremer; Patrick M Schlievert; Christopher A Squier
Journal:  Am J Obstet Gynecol       Date:  2003-12       Impact factor: 8.661

10.  Molecular identification of a danger signal that alerts the immune system to dying cells.

Authors:  Yan Shi; James E Evans; Kenneth L Rock
Journal:  Nature       Date:  2003-09-07       Impact factor: 49.962

View more
  37 in total

1.  Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury.

Authors:  Georgia A Wilke; Juliane Bubeck Wardenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

Review 2.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

3.  Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone.

Authors:  Peter G Maamary; Nouri L Ben Zakour; Jason N Cole; Andrew Hollands; Ramy K Aziz; Timothy C Barnett; Amanda J Cork; Anna Henningham; Martina Sanderson-Smith; Jason D McArthur; Carola Venturini; Christine M Gillen; Joshua K Kirk; Dwight R Johnson; William L Taylor; Edward L Kaplan; Malak Kotb; Victor Nizet; Scott A Beatson; Mark J Walker
Journal:  FASEB J       Date:  2012-08-09       Impact factor: 5.191

4.  Staphylococcus aureus toxin antibodies: Good companions of antibiotics and vaccines.

Authors:  Fabio Bagnoli
Journal:  Virulence       Date:  2017-03-07       Impact factor: 5.882

5.  A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).

Authors:  Laura M Breshears; Patrick M Schlievert; Marnie L Peterson
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

Review 6.  Molecular insight into invasive group A streptococcal disease.

Authors:  Jason N Cole; Timothy C Barnett; Victor Nizet; Mark J Walker
Journal:  Nat Rev Microbiol       Date:  2011-09-16       Impact factor: 60.633

7.  Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus.

Authors:  Ying-Chi Lin; Michele J Anderson; Petra L Kohler; Kristi L Strandberg; Michael E Olson; Alexander R Horswill; Patrick M Schlievert; Marnie L Peterson
Journal:  Biochemistry       Date:  2011-07-21       Impact factor: 3.162

8.  New insights into the prevention of staphylococcal infections and toxic shock syndrome.

Authors:  Ying-Chi Lin; Marnie L Peterson
Journal:  Expert Rev Clin Pharmacol       Date:  2010-11-01       Impact factor: 5.045

Review 9.  Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome.

Authors:  Amanda J Brosnahan; Patrick M Schlievert
Journal:  FEBS J       Date:  2011-05-19       Impact factor: 5.542

Review 10.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.